Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 282

1.

The role of MRI for detection and staging of radio- and focal therapy-recurrent prostate cancer.

van der Poel H, Grivas N, van Leeuwen P, Heijmink S, Schoots I.

World J Urol. 2019 Feb 20. doi: 10.1007/s00345-019-02677-y. [Epub ahead of print]

PMID:
30788590
2.

Frequent clonal relations between metastases and non-index prostate cancer lesions.

Kneppers J, Krijgsman O, Melis M, de Jong J, Peeper DS, Bekers E, van der Poel HG, Zwart W, Bergman AM.

JCI Insight. 2019 Jan 24;4(2). pii: 124756. doi: 10.1172/jci.insight.124756. [Epub ahead of print]

3.

Technologies for image-guided surgery for managing lymphatic metastases in prostate cancer.

van Leeuwen FWB, Winter A, van Der Poel HG, Eiber M, Suardi N, Graefen M, Wawroschek F, Maurer T.

Nat Rev Urol. 2019 Mar;16(3):159-171. doi: 10.1038/s41585-018-0140-8. Review.

PMID:
30644446
4.

Optimized ChIP-seq method facilitates transcription factor profiling in human tumors.

Singh AA, Schuurman K, Nevedomskaya E, Stelloo S, Linder S, Droog M, Kim Y, Sanders J, van der Poel H, Bergman AM, Wessels LF, Zwart W.

Life Sci Alliance. 2018 Dec 28;2(1):e201800115. doi: 10.26508/lsa.201800115. eCollection 2019 Feb.

5.

Linking surgical skills to postoperative outcomes: a Delphi study on the robot-assisted radical prostatectomy.

Beulens AJW, Brinkman WM, Van der Poel HG, Vis AN, van Basten JP, Meijer RP, Wijburg CJ, Hendrikx AJM, van Merriënboer JJG, Wagner C.

J Robot Surg. 2019 Jan 4. doi: 10.1007/s11701-018-00916-9. [Epub ahead of print]

PMID:
30610535
6.

Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external-beam radiation therapy.

Dinis Fernandes C, van Houdt PJ, Heijmink SWTPJ, Walraven I, Keesman R, Smolic M, Ghobadi G, van der Poel HG, Schoots IG, Pos FJ, van der Heide UA.

J Magn Reson Imaging. 2018 Dec 25. doi: 10.1002/jmri.26581. [Epub ahead of print]

PMID:
30585368
7.

Outcome of sentinel lymph node biopsy in patients with clinically non-metastatic renal cell carcinoma.

Kuusk T, De Bruijn R, Brouwer OR, De Jong J, Donswijk M, Hendricksen K, Horenblas S, Jóźwiak K, Prevoo W, Valdés Olmos RA, Van Der Poel HG, Van Rhijn BW, Wit EM, Bex A.

Scand J Urol. 2018 Oct - Dec;52(5-6):411-418. doi: 10.1080/21681805.2018.1531057. Epub 2018 Dec 11.

PMID:
30526184
8.

Posterior, Anterior, and Periurethral Surgical Reconstruction of Urinary Continence Mechanisms in Robot-assisted Radical Prostatectomy: A Description and Video Compilation of Commonly Performed Surgical Techniques.

Vis AN, van der Poel HG, Ruiter AEC, Hu JC, Tewari AK, Rocco B, Patel VR, Razdan S, Nieuwenhuijzen JA.

Eur Urol. 2018 Dec 2. pii: S0302-2838(18)30934-5. doi: 10.1016/j.eururo.2018.11.035. [Epub ahead of print]

PMID:
30514568
9.

An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors.

Kuusk T, Donswijk ML, Valdés Olmos RA, De Bruijn RE, Brouwer OR, Hendricksen K, Horenblas S, Jóźwiak K, Prevoo W, Van Der Poel HG, Van Rhijn BWG, Wit EM, Bex A.

EJNMMI Res. 2018 Dec 3;8(1):105. doi: 10.1186/s13550-018-0460-y.

10.

Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer.

Lam TBL, MacLennan S, Plass K, Willemse PM, Mason MD, Cornford P, Donaldson J, Davis NF, Dell'Oglio P, Fankhauser C, Grivas N, Ingels A, Lardas M, Liew M, Pang KH, Paterson C, Omar MI, Zattoni F, Buddingh KT, Van den Broeck T, Cumberbatch MG, Fossati N, Gross T, Moris L, Schoots IG, van den Bergh RCN, Briers E, Fanti S, De Santis M, Gillessen S, Grummet JP, Henry AM, van der Poel HG, van der Kwast TH, Rouvière O, Tilki D, Wiegel T, N'Dow J, Van Poppel H, Mottet N.

Eur Urol. 2019 Apr;75(4):699-702. doi: 10.1016/j.eururo.2018.11.009. Epub 2018 Nov 22. No abstract available.

PMID:
30473433
11.

The value of a 1-day multidisciplinary robot surgery training for novice robot surgeons.

Beulens AJW, Brinkman WM, Porte PJ, Meijer RP, van Merriënboer JJG, Van der Poel HG, Wagner C.

J Robot Surg. 2018 Nov 22. doi: 10.1007/s11701-018-0894-2. [Epub ahead of print]

PMID:
30467702
12.

Sentinel lymph node imaging in urologic oncology.

Mehralivand S, van der Poel H, Winter A, Choyke PL, Pinto PA, Turkbey B.

Transl Androl Urol. 2018 Oct;7(5):887-902. doi: 10.21037/tau.2018.08.23. Review.

13.

Quantitative 3-T multi-parametric MRI and step-section pathology of recurrent prostate cancer patients after radiation therapy.

Dinis Fernandes C, Ghobadi G, van der Poel HG, de Jong J, Heijmink SWTPJ, Schoots I, Walraven I, van Houdt PJ, Smolic M, Pos FJ, van der Heide UA.

Eur Radiol. 2018 Nov 12. doi: 10.1007/s00330-018-5819-y. [Epub ahead of print]

PMID:
30421016
14.

Sentinel Node Biopsy in Clinical Stage I Testicular Cancer Enables Early Detection of Occult Metastatic Disease.

Blok JM, Kerst JM, Vegt E, Brouwer OR, Meijer RP, Bosch JLHR, Bex A, van der Poel HG, Horenblas S.

BJU Int. 2018 Nov 11. doi: 10.1111/bju.14618. [Epub ahead of print]

PMID:
30417511
15.

(Cost-)effectiveness of an internet-based physical activity support program (with and without physiotherapy counselling) on physical activity levels of breast and prostate cancer survivors: design of the PABLO trial.

van de Wiel HJ, Stuiver MM, May AM, van Grinsven S, Aaronson NK, Retèl VP, Oldenburg HSA, van der Poel HG, Horenblas S, van Harten WH, Groen WG.

BMC Cancer. 2018 Nov 6;18(1):1073. doi: 10.1186/s12885-018-4927-z.

16.

Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond

Linder S, van der Poel HG, Bergman AM, Zwart W, Prekovic S.

Endocr Relat Cancer. 2018 Oct 31;26(1):R31-R52. doi: 10.1530/ERC-18-0289.

17.

Ultrasensitive prostate-specific antigen level as a predictor of biochemical progression after robot-assisted radical prostatectomy: Towards risk adapted follow-up.

Grivas N, de Bruin D, Barwari K, van Muilekom E, Tillier C, van Leeuwen PJ, Wit E, Kroese W, van der Poel H.

J Clin Lab Anal. 2019 Feb;33(2):e22693. doi: 10.1002/jcla.22693. Epub 2018 Oct 26.

PMID:
30365194
18.

Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.

Van den Broeck T, van den Bergh RCN, Arfi N, Gross T, Moris L, Briers E, Cumberbatch M, De Santis M, Tilki D, Fanti S, Fossati N, Gillessen S, Grummet JP, Henry AM, Lardas M, Liew M, Rouvière O, Pecanka J, Mason MD, Schoots IG, van Der Kwast TH, van Der Poel HG, Wiegel T, Willemse PM, Yuan Y, Lam TB, Cornford P, Mottet N.

Eur Urol. 2018 Oct 17. pii: S0302-2838(18)30752-8. doi: 10.1016/j.eururo.2018.10.011. [Epub ahead of print] Review.

PMID:
30342843
19.

SNPSelect: A scalable and flexible targeted sequence-based genotyping solution.

Hogers RCJ, de Ruiter M, Huvenaars KHJ, van der Poel H, Janssen A, van Eijk MJT, van Orsouw NJ.

PLoS One. 2018 Oct 12;13(10):e0205577. doi: 10.1371/journal.pone.0205577. eCollection 2018.

20.

Radical Prostatectomy after Vascular Targeted Photodynamic Therapy with Padeliporfin: Feasibility, and Early and Intermediate Results.

Pierrard V, Lebdai S, Kleinclauss F, Azzouzi AR, Terrier JE, Fortier E, Joniau S, Van Der Poel H, Salomon G, Casanova J, Medina-Lopez RA, Potiron E, Rigaud J, Vincendeau S, Rassweiler J, Villers A, Gaston R, Saussine C, Giai J, Gaillac B, Emberton M, Ruffion A.

J Urol. 2019 Feb;201(2):315-321. doi: 10.1016/j.juro.2018.08.084.

PMID:
30248343
21.

Reply to Massimo Valerio, Mark Emberton, and Hashim U. Ahmed's Letter to the Editor re: Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, et al. Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:84-91.

van der Poel HG, van den Bergh RCN, Briers E, Cornford P, Govorov A, Henry AM, Lam TB, Mason MD, Rouvière O, De Santis M, Wiegel T, Willemse PM, van Poppel H, Mottet N.

Eur Urol. 2019 Feb;75(2):e23-e24. doi: 10.1016/j.eururo.2018.08.043. Epub 2018 Sep 17. No abstract available.

PMID:
30237024
22.

Comprehensive Assessment of Indocyanine Green Usage: One Tracer, Multiple Urological Applications.

van der Poel HG, Grivas N, van Leeuwen F.

Eur Urol Focus. 2018 Sep;4(5):665-668. doi: 10.1016/j.euf.2018.08.017. Epub 2018 Sep 7. Review.

PMID:
30197043
23.

Editorial Comment.

van den Bergh RCN, van der Poel HG, Murphy DG.

J Urol. 2018 Dec;200(6):1254-1255. doi: 10.1016/j.juro.2018.06.094. Epub 2018 Sep 5. No abstract available.

PMID:
30193091
24.

Towards an individualized approach for predicting post-prostatectomy urinary incontinence: the role of nerve preservation and urethral stump length.

van der Poel HG, Grivas N.

BJU Int. 2018 Sep;122(3):354-355. doi: 10.1111/bju.14205. No abstract available.

PMID:
30187656
25.

A prediction model relating the extent of intraoperative fascia preservation to erectile dysfunction after nerve-sparing robot-assisted radical prostatectomy.

KleinJan GH, Sikorska K, Korne CM, Brouwer OR, Buckle T, Tillier C, van der Roest RCM, de Jong J, van Leeuwen FWB, van der Poel HG.

J Robot Surg. 2018 Sep 3. doi: 10.1007/s11701-018-0867-5. [Epub ahead of print]

PMID:
30178300
26.

68Ga PSMA PET/CT predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate and high-risk prostate cancer.

van Leeuwen PJ, Donswijk M, Nandurkar R, Stricker P, Ho B, Heijmink S, Wit EMK, Tillier C, van Muilenkom E, Nguyen Q, van der Poel HG, Emmett L.

BJU Int. 2018 Aug 3. doi: 10.1111/bju.14506. [Epub ahead of print]

PMID:
30074667
27.

Robot-assisted laparoscopic surgery using DROP-IN radioguidance: first-in-human translation.

Meershoek P, van Oosterom MN, Simon H, Mengus L, Maurer T, van Leeuwen PJ, Wit EMK, van der Poel HG, van Leeuwen FWB.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):49-53. doi: 10.1007/s00259-018-4095-z. Epub 2018 Jul 27.

28.

[The accuracy of patients' perceptions of the risks associated with localised prostate cancer treatments].

van Stam MA, Aaronson NK, van der Poel HG, van der Voort van Zyp JRN, Tillier CN, Horenblas S, Bosch JLHR.

Ned Tijdschr Geneeskd. 2018 Jun 7;162. pii: D2522. Dutch.

PMID:
30040303
29.

Robot-assisted extended lymphadenectomy in prostate cancer.

Tyritzis SI, Kalampokis N, Grivas N, van der Poel H, Wiklund NP.

Minerva Chir. 2019 Feb;74(1):88-96. doi: 10.23736/S0026-4733.18.07780-5. Epub 2018 Jul 23.

PMID:
30037178
30.

The value of periprostatic fascia thickness and fascia preservation as prognostic factors of erectile function after nerve-sparing robot-assisted radical prostatectomy.

Grivas N, van der Roest RC, de Korne CM, KleinJan GH, Sikorska K, Schoots IG, Tillier C, van der Broek B, Jalink K, Heijmink SWTJP, Buckle T, van Leeuwen FWB, van der Poel HG.

World J Urol. 2019 Feb;37(2):309-315. doi: 10.1007/s00345-018-2387-3. Epub 2018 Jun 23.

PMID:
29936567
31.

Prostate sparing cystectomy for bladder cancer: A two-center study.

Voskuilen CS, Fransen van de Putte EE, Pérez-Reggeti JI, van Werkhoven E, Mertens LS, van Rhijn BWG, Saad M, Bex A, Cathelineau X, van der Poel HG, Horenblas S, Sanchez-Salas R, Meijer RP.

Eur J Surg Oncol. 2018 Sep;44(9):1446-1452. doi: 10.1016/j.ejso.2018.05.032. Epub 2018 Jun 8.

PMID:
29929902
32.

Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.

Cioni B, Nevedomskaya E, Melis MHM, van Burgsteden J, Stelloo S, Hodel E, Spinozzi D, de Jong J, van der Poel H, de Boer JP, Wessels LFA, Zwart W, Bergman AM.

Mol Oncol. 2018 Aug;12(8):1308-1323. doi: 10.1002/1878-0261.12327. Epub 2018 Jul 10.

33.

Multispectral-Fluorescence Imaging as a Tool to Separate Healthy from Disease-Related Lymphatic Anatomy During Robot-Assisted Laparoscopy.

Meershoek P, KleinJan GH, van Oosterom MN, Wit EMK, van Willigen DM, Bauwens KP, van Gennep EJ, Mottrie AM, van der Poel HG, van Leeuwen FWB.

J Nucl Med. 2018 Nov;59(11):1757-1760. doi: 10.2967/jnumed.118.211888. Epub 2018 May 18.

PMID:
29777008
34.

How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.

Gandaglia G, van den Bergh RCN, Tilki D, Fossati N, Ost P, Surcel CI, Sooriakumaran P, Tsaur I, Valerio M, Kretschmer A, Zaffuto E, Salomon L, Montorsi F, Graefen M, van der Poel H, de la Taille A, Briganti A, Ploussard G; European Association of Urology Young Academic Urologists Working Party on Prostate Cancer (EAU-YAUWP).

BJU Int. 2018 Nov;122(5):823-830. doi: 10.1111/bju.14391. Epub 2018 Jun 3.

PMID:
29772103
35.

Cognitive training for technical and non-technical skills in robotic surgery: a randomised controlled trial.

Raison N, Ahmed K, Abe T, Brunckhorst O, Novara G, Buffi N, McIlhenny C, van der Poel H, van Hemelrijck M, Gavazzi A, Dasgupta P.

BJU Int. 2018 Dec;122(6):1075-1081. doi: 10.1111/bju.14376. Epub 2018 Jun 12.

PMID:
29733492
36.

The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodes.

KleinJan GH, van Werkhoven E, van den Berg NS, Karakullukcu MB, Zijlmans HJMAA, van der Hage JA, van de Wiel BA, Buckle T, Klop WMC, Horenblas S, Valdés Olmos RA, van der Poel HG, van Leeuwen FWB.

Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1915-1925. doi: 10.1007/s00259-018-4028-x. Epub 2018 Apr 25.

38.

The New Standard: Personalised Information about the Risks and Benefits of Treatment Strategies for Localised Prostate Cancer.

van Stam MA, van der Poel H.

Eur Urol. 2018 Jul;74(1):34-36. doi: 10.1016/j.eururo.2018.03.018. Epub 2018 Apr 13. No abstract available.

PMID:
29656852
39.

Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study.

Drost FH, Rannikko A, Valdagni R, Pickles T, Kakehi Y, Remmers S, van der Poel HG, Bangma CH, Roobol MJ; PRIAS study group.

Transl Androl Urol. 2018 Feb;7(1):98-105. doi: 10.21037/tau.2017.12.28.

40.

Establishing objective benchmarks in robotic virtual reality simulation at the level of a competent surgeon using the RobotiX Mentor simulator.

Watkinson W, Raison N, Abe T, Harrison P, Khan S, Van der Poel H, Dasgupta P, Ahmed K.

Postgrad Med J. 2018 May;94(1111):270-277. doi: 10.1136/postgradmedj-2017-135351. Epub 2018 Mar 6.

PMID:
29511043
41.

Shared Decision Making in Prostate Cancer Care-Encouraging Every Patient to be Actively Involved in Decision Making or Ensuring the Patient Preferred Level of Involvement?

van Stam MA, Pieterse AH, van der Poel HG, Bosch JLHR, Tillier C, Horenblas S, Aaronson NK.

J Urol. 2018 Sep;200(3):582-589. doi: 10.1016/j.juro.2018.02.3091. Epub 2018 Mar 6.

PMID:
29501555
42.

Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer.

Buckle T, van Willigen DM, Spa SJ, Hensbergen AW, van der Wal S, de Korne CM, Welling MM, van der Poel HG, Hardwick JCH, van Leeuwen FWB.

J Nucl Med. 2018 Jun;59(6):986-992. doi: 10.2967/jnumed.117.205575. Epub 2018 Feb 15.

PMID:
29449447
43.

Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018.

van der Poel HG, van den Bergh RCN, Briers E, Cornford P, Govorov A, Henry AM, Lam TB, Mason MD, Rouvière O, De Santis M, Willemse PM, van Poppel H, Mottet N.

Eur Urol. 2018 Jul;74(1):84-91. doi: 10.1016/j.eururo.2018.01.001. Epub 2018 Jan 17.

44.

Seminal vesicle invasion on multi-parametric magnetic resonance imaging: Correlation with histopathology.

Grivas N, Hinnen K, de Jong J, Heemsbergen W, Moonen L, Witteveen T, van der Poel H, Heijmink S.

Eur J Radiol. 2018 Jan;98:107-112. doi: 10.1016/j.ejrad.2017.11.013. Epub 2017 Nov 21.

PMID:
29279147
45.

Computer-assisted surgery: virtual- and augmented-reality displays for navigation during urological interventions.

van Oosterom MN, van der Poel HG, Navab N, van de Velde CJH, van Leeuwen FWB.

Curr Opin Urol. 2018 Mar;28(2):205-213. doi: 10.1097/MOU.0000000000000478.

PMID:
29278582
46.

Lymphatic Drainage from Renal Tumors In Vivo: A Prospective Sentinel Node Study Using SPECT/CT Imaging.

Kuusk T, De Bruijn R, Brouwer OR, De Jong J, Donswijk M, Grivas N, Hendricksen K, Horenblas S, Prevoo W, Valdés Olmos RA, Van Der Poel HG, Van Rhijn BWG, Wit EM, Bex A.

J Urol. 2018 Jun;199(6):1426-1432. doi: 10.1016/j.juro.2017.11.112. Epub 2017 Dec 6.

PMID:
29223390
47.

Navigation of Fluorescence Cameras during Soft Tissue Surgery-Is it Possible to Use a Single Navigation Setup for Various Open and Laparoscopic Urological Surgery Applications?

van Oosterom MN, Meershoek P, KleinJan GH, Hendricksen K, Navab N, van de Velde CJH, van der Poel HG, van Leeuwen FWB.

J Urol. 2018 Apr;199(4):1061-1068. doi: 10.1016/j.juro.2017.09.160. Epub 2017 Nov 22.

PMID:
29174485
48.

Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.

Mottet N, De Santis M, Briers E, Bourke L, Gillessen S, Grummet JP, Lam TB, van der Poel HG, Rouvière O, van den Bergh RCN, Cornford P.

Eur Urol. 2017 Nov 2. pii: S0302-2838(17)30839-4. doi: 10.1016/j.eururo.2017.09.029. [Epub ahead of print]

PMID:
29103760
49.

The Validation of a Novel Robot-Assisted Radical Prostatectomy Virtual Reality Module.

Harrison P, Raison N, Abe T, Watkinson W, Dar F, Challacombe B, Van Der Poel H, Khan MS, Dasgupa P, Ahmed K.

J Surg Educ. 2018 May - Jun;75(3):758-766. doi: 10.1016/j.jsurg.2017.09.005. Epub 2017 Sep 30.

PMID:
28974429
50.

The accuracy of patients' perceptions of the risks associated with localised prostate cancer treatments.

van Stam MA, van der Poel HG, van der Voort van Zyp JRN, Tillier CN, Horenblas S, Aaronson NK, Ruud Bosch JLH.

BJU Int. 2018 Mar;121(3):405-414. doi: 10.1111/bju.14034. Epub 2017 Oct 27.

Supplemental Content

Loading ...
Support Center